Master Alliance Provisions Guide (MAPGuide)

Valneva – Serum Institute of India, Chikungunya Vaccine License Agreement

  • Term & termination | Term of agreement

17. Term and Termination

17.1 Term. This Agreement shall come into force on the Effective Date and, unless terminated earlier in accordance with the provisions under Article 17, this Agreement shall expire on a country-by-country basis on the later of: the expiry in such country of the last Valid Claim of the Licensed Patents licensed to SIIPL under this Agreement or [***] after the First Commercial Sale of the SIIPL Product in such country (collectively “Term“).